Delivery Order SPE2DB20D2104-SPE2DB25FMKFF
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC6G6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,757.30 Firm Fixed Price contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a medical product, with a period of performance through July 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.13 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,002.86, is a delivery order with a firm fixed price for the supply of VRAYLAR 1.5 MG CAPSULE 30S to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,732.21, is a firm fixed price delivery order for 4563154586 VRAYLAR 1.5 MG CAPSULE 30S. The contract has an ultimate completion date of December 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $10,550.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, identified as Delivery Order SPE2DB20D1100|SPE2DB24FA3F9, is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of February 21, 2024. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $3,572.08 and an ultimate completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,810.78, is for the delivery of VRAYLAR 3 MG CAPSULES. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award, with a ceiling value of $2,764.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2024 and does not have a set-aside designation, indicating open competition. In addition to this specific contract,...
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB25FV7HC, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,083.95 firm-fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a performance period ending on December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,363.89 firm fixed-price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...